ClinicalTrials.Veeva

Menu

Effect of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease

T

Tanta University

Status and phase

Enrolling
Phase 3

Conditions

Parkinson's Disease

Treatments

Drug: Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers

Study type

Interventional

Funder types

Other

Identifiers

NCT05576818
Synbiotics Parkinson's disease

Details and patient eligibility

About

This study aims to investigate the possible efficacy and safety of synbiotic preparation of Lactobacillus acidophilus probiotic with prebiotic fibers as an adjuvant therapy in the treatment of Parkinson's disease

Enrollment

66 estimated patients

Sex

All

Ages

45 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 45 and 65 years old
  • Both sexes
  • Patients with Parkinson's disease on dopamine replacement therapy
  • Modified Hoehn and Yahr stage, MHY 1-4

Exclusion criteria

  • Patients who are currently using or used antibiotics therapy in the preceding month
  • Patients who are currently using or used other probiotic products in the preceding two weeks
  • Patients scheduled to undergo GIT surgery or those underwent GIT surgery
  • Patients with Known allergy to probiotics
  • Patients receiving artificial enteral or intravenous nutrition
  • Patients with depression and/or psychosis
  • Patients taking antioxidant and/or anti-inflammatory medications
  • Patients with Hyperthyroidism
  • Patients with inflammatory condition and/or condition involving oxidative stress
  • Smokers
  • Modified Hoehn & Yahr stage MHY 5

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

66 participants in 2 patient groups

Control group
No Intervention group
Description:
this group will include 33 patients who will receive their standard dopamine replacement therapy for 3 months
Synbiotic group
Active Comparator group
Description:
this group will involve 33 patients who will receive Synbiotic preparation containing Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers 2 sachets daily together with their standard dopamine replacement therapy for 3 months
Treatment:
Drug: Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers

Trial contacts and locations

1

Loading...

Central trial contact

Mohamed E Ramadan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems